US Patent 9546132 4-(p-quinonyl)-2-hydroxybutanamide derivatives for treatment of mitochondrial diseases
Patent 9546132 was granted and assigned to Edison Pharmaceuticals on January, 2017 by the United States Patent and Trademark Office.
Name
# Contributions
Last Contribution
Find more entities like US Patent 9546132 4-(p-quinonyl)-2-hydroxybutanamide derivatives for treatment of mitochondrial diseases
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.